BYNFEZIA
Live / Registered — Registered — Section 8 accepted (as of 10 Sept 2026)
What this means for you
Registered since 04 Aug 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Aug 2030: the §8 & §9 renewal).
Record
- Serial number
- 88620337
- Registration number
- 6116740
- Mark type
- Word mark
- Filed
- 17 Sept 2019
- Published for opposition
- 19 May 2020
- Registered
- 04 Aug 2020
- Next maintenance filing
- §8 & §9 renewal, due by 04 Aug 2030 (grace period to 04 Feb 2031)
- Attorney of record
- Craig Kuchii, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medicinal preparation for the management of gastrointestinal endocrine tumors; Pharmaceutical and medicinal preparation for the management of acromegaly, carcinoid tumors, and vasoactive intestinal peptide tumors
Owner
- Sun Pharmaceutical Industries Limited, Mumbai, Maharashtra, IN
- Sun Pharmaceutical Industries Limited, Mumbai, Maharashtra, IN
- Sun Pharmaceutical Industries Limited, Mumbai, Maharashtra, IN
Prosecution history
- 10 Sept 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 10 Sept 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 07 Sept 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Jul 2026 — TEAS SECTION 8 RECEIVED
- 04 Aug 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 Aug 2020 — REGISTERED-PRINCIPAL REGISTER
- 19 May 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 May 2020 — PUBLISHED FOR OPPOSITION
- 29 Apr 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Apr 2020 — ELECTRONIC RECORD REVIEW COMPLETE
- 10 Apr 2020 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 03 Apr 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Apr 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Apr 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Apr 2020 — ASSIGNED TO LIE